M&A

What Lies Ahead for Pfizer, Allergan as their Merger Sees Dust
Bidness, ETC
Wed, 04/6/16 - 09:37 am
Pfizer
Allergan
M&A
tax inversions
The Allergan-Pfizer Merger Is Now Dead, But Allergan Isn't
Seeking Alpha
Wed, 04/6/16 - 09:35 am
Allergan
Pfizer
M&A
tax inversions
Pfizer to Terminate $160 Billion Merger With Allergan
Bloomberg
Tue, 04/5/16 - 10:32 pm
Pfizer
Allergan
M&A
tax inversions
Allergan's Future Gets Murky
Motley Fool
Tue, 04/5/16 - 10:17 pm
Allergan
tax inversions
Pfizer
M&A
Allergan Buyout History Could Scuttle Pfizer Deal, Say Analysts
Investors.com
Tue, 04/5/16 - 08:54 pm
Allergan
Pfizer
M&A
tax inversions
[video]Pfizer-Allergan and the New U.S. Tax Inversion Rule
Bloomberg
Tue, 04/5/16 - 08:58 am
Pfizer
Allergan
tax inversions
M&A
Would Pfizer and AstraZeneca Both Revisit That $100 Billion Deal?
Forbes
Tue, 04/5/16 - 08:57 am
Pfizer
AstraZeneca
M&A
Why Gilead Sciences and Amgen Can Eye Medivation As Acquisition Target
Bidness, ETC
Tue, 04/5/16 - 08:48 am
Gilead Sciences
Amgen
Medivation
M&A
This Could Be the Next Big Pharma Buyout
Motley Fool
Sun, 04/3/16 - 10:56 am
Big Pharma
M&A
JNJ
Geron
Acadia
Jazz Pharmaceuticals
Bluebird Bio
Kite Pharma
Buying These 2 Drug Developers Would Make a Lot of Sense for Johnson & Johnson
Motley Fool
Thu, 03/31/16 - 11:05 am
JNJ
drug development
M&A
Geron
Achillion
FTC Can Derail Pfizer-Allergan Merger in More Ways Than One
Bidness, ETC
Thu, 03/31/16 - 10:38 am
FTC
Pfizer
Allergan
M&A
Why Biogen Should Acquire ACADIA Pharmaceuticals
Bidness, ETC
Thu, 03/31/16 - 10:06 am
Biogen
Acadia
M&A
Parkinson's Disease Psychosis
Nuplazid
Medivation working with JPMorgan on takeover approaches -sources
Yahoo/Reuters
Wed, 03/30/16 - 09:27 pm
Medivation
JPMorgan
M&A
Pfizer-Allergan Deal Faces In-Depth Antitrust Probe by U.S.
Bloomberg
Wed, 03/30/16 - 09:17 pm
Pfizer
Allergan
M&A
antitrust
Could Mylan NV be Interested in Acquiring Valeant Pharma's Assets?
Bidness, ETC
Tue, 03/29/16 - 10:21 pm
Mylan Labs
Valeant Pharmaceuticals
M&A
8 Biotech Stocks That Have a ‘Greater Probability’ of Being Acquired
Barron's
Tue, 03/29/16 - 12:24 pm
biotech
M&A
Ardelyx
Ophthotech
Medivation
Puma Biotechnology
Ultragenyx
Portola Pharmaceuticals
Versartis
Relypsa
Is ZIOPHARM Poised For Acquisition?
Seeking Alpha
Mon, 03/28/16 - 06:57 pm
Ziopharm
M&A
Intrexon
Can Bristol-Myers Win the Autoimmune Market with Padlock Acquisition?
Bidness, ETC
Mon, 03/28/16 - 08:46 am
Bristol-Myers Squibb
Padlock Therapeutics
autoimmune disease
M&A
Allergan Is a Good Buy for Investors, With or Without Pfizer
TheStreet.com
Thu, 03/24/16 - 09:57 am
Allergan
Pfizer
M&A
​​Behind Bristol-Myers' $600M acquisition of an Atlas biotech startup
Bizjournals.com
Wed, 03/23/16 - 04:17 pm
Bristol-Myers Squibb
Padlock Therapeutics
M&A

Pages